Section: Partnerships and Cooperations

International Initiatives

Inria International Partners

Informal International Partners

• Astrid Lindgrens Hospital, Stockholm University: Collaboration with Anna Nilsson and Shanie Saghafian-Hedengren on RNA sequencing of stromal cells (pilot study done in 2017).

• Childhood Leukaemia Investigation Prague (CLIP), Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic: Collaboration with Michaela Kotrová and Eva Fronkova on leukemia diagnosis and follow-up.

• CWI Amsterdam: Collaboration with Alexander Schoenhuth on data structures for genomic data.

• Department of Statitics, North Carolina State University: Collaboration with Donald E. K. Martin on spaced seeds coverage [21].

• Département des Sciences de la Vie, Faculté des Sciences de Liège: Collaboration with Denis Beaurain on nonribosomal peptides.

• Gembloux Agro-Bio Tech, Université de Liège: Collaboration with Philippe Jacques on nonribosomal peptides.

• Institute of Biosciences and Bioresources, Bari: Collaboration with Nunzia Scotti on the assembly of plant mitochondrial genomes.

• Medvedev lab, The Pennsylvania State University: Collaboration with Paul Medvedev on algorithms and data structures for genomic data, e.g. the Allsome Sequence Bloom Trees.

• Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark: Collaboration with Tilmann Weber on nonribosomal peptides.

• Proteome Informatics Group, Swiss Institute of Bioinformatics: Collaboration with Frédérique Lisacek on nonribosomal peptides.

• School of Social and Community Medicine, University of Bristol: Collaboration with John Moppett and Stephanie Wakeman on leukemia diagnosis follow-up.

• Theoretical Biochemistry Group, Universität Wien: Collaboration with Andrea Tanzer and Ronny Lorenz on RNA folding and RNA kinetics.

Participation in Other International Programs

• Participation in the EuroClonality-NGS consortium. This consortium aims at standardizing the study of immune repertoire, clonality and minimal residual disease in leukemia at the european level. We are part of the bioinformatics workgroup led by Nikos Darzentas (CEITEC, Brno, Czech Republic). Withing this consortium, we participated to a lead opinion paper on immunohematology [20].